Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker CL
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Lorrie M. Norrington Officer | CL Colgate-Palmolive Company | 4,170 | $414.1K | — | Nov 5, 2026 | Form 4 ↗ 4 days later · 4,170 shares | Form 144 ↗ |
| Nov 5, 2026 | Noel R. Wallace Officer | CL Colgate-Palmolive Company | 20,000 | $2.0M | — | Nov 5, 2026 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Nov 4, 2026 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 19,938 | $2.0M | — | Nov 4, 2026 | Form 4 ↗ 2 days later · 19,938 shares | Form 144 ↗ |
| Nov 4, 2026 | John Hazlin Officer | CL Colgate-Palmolive Company | 23,376 | $2.3M | — | Nov 4, 2026 | Form 4 ↗ 2 days later · 23,376 shares | Form 144 ↗ |
| Aug 24, 2026 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 10,000 | $920.5K | — | Aug 24, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Aug 6, 2026 | John T. Cahill Director | CL Colgate-Palmolive Company | 4,170 | $389.4K | — | Aug 6, 2026 | Form 4 ↗ 1 day later · 4,170 shares | Form 144 ↗ |
| Aug 5, 2026 | Noel R. Wallace Officer | CL Colgate-Palmolive Company | 161,021 | $14.9M | — | Aug 5, 2026 | Form 4 ↗ 1 day later · 322,042 shares | Form 144 ↗ |
| Aug 4, 2026 | Noel R. Wallace Officer | CL Colgate-Palmolive Company | 161,021 | $14.8M | — | Aug 4, 2026 | Form 4 ↗ 2 days later · 322,042 shares | Form 144 ↗ |
| Aug 4, 2026 | Steven A. Cahillane Officer | CL Colgate-Palmolive Company | 1,762 | $159.6K | — | Aug 4, 2026 | — | Form 144 ↗ |
| Feb 12, 2026 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 15,000 | $1.5M | — | Feb 12, 2026 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Feb 11, 2026 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 35,000 | $3.3M | — | Feb 11, 2026 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Feb 10, 2026 | John Hazlin Officer | CL Colgate-Palmolive Company | 20,989 | $2.0M | — | Feb 10, 2026 | Form 4 ↗ 2 days later · 20,989 shares | Form 144 ↗ |
| Feb 4, 2026 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 22,000 | $2.1M | — | Feb 4, 2026 | Form 4 ↗ 2 days later · 22,000 shares | Form 144 ↗ |
| Feb 4, 2026 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 45,568 | $4.3M | — | Feb 4, 2026 | Form 4 ↗ 2 days later · 45,568 shares | Form 144 ↗ |
| Feb 4, 2026 | Stanley J. Sutula III Officer | CL Colgate-Palmolive Company | 97,843 | $9.2M | — | Feb 4, 2026 | Form 4 ↗ 2 days later · 97,843 shares | Form 144 ↗ |
| Nov 22, 2024 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 33,333 | $3.2M | 10b5-1 | Nov 22, 2024 | Form 4 ↗ 4 days later · 33,333 shares | Form 144 ↗ |
| Nov 5, 2024 | Stanley J. Sutula III Officer | CL Colgate-Palmolive Company | 45,410 | $4.3M | — | Nov 5, 2024 | Form 4 ↗ 2 days later · 45,410 shares | Form 144 ↗ |
| Nov 4, 2024 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 20,032 | $1.9M | — | Nov 4, 2024 | Form 4 ↗ 1 day later · 20,032 shares | Form 144 ↗ |
| Nov 1, 2024 | Stanley J. Sutula III Officer | CL Colgate-Palmolive Company | 50,000 | $4.7M | — | Nov 1, 2024 | Form 4 ↗ 4 days later · 50,000 shares | Form 144 ↗ |
| Aug 23, 2024 | Hundmejean Martina Director | CL Colgate-Palmolive Company | 2,313 | $240.2K | — | Aug 23, 2024 | — | Form 144 ↗ |
| Aug 8, 2024 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 22,000 | $2.3M | — | Aug 8, 2024 | — | Form 144 ↗ |
| Aug 8, 2024 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 14,794 | $1.5M | — | Aug 8, 2024 | Form 4 ↗ 89 days later · 20,032 shares | Form 144 ↗ |
| Jul 31, 2024 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 40,000 | $4.0M | — | Jul 31, 2024 | — | Form 144 ↗ |
| Jun 4, 2024 | Stephen I. Sadove Revocable Trust U/A/D 06/07/2008 Former Director | CL Colgate-Palmolive Company | 5,000 | $469.4K | — | Jun 4, 2024 | — | Form 144 ↗ |
| May 14, 2024 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 22,250 | $2.1M | — | May 14, 2024 | — | Form 144 ↗ |
| May 13, 2024 | Stephen I. Sadove Former Director | CL Colgate-Palmolive Company | 4,155 | $393.9K | — | May 13, 2024 | — | Form 144 ↗ |
| May 9, 2024 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 12,000 | $1.1M | — | May 9, 2024 | — | Form 144 ↗ |
| May 1, 2024 | John P. Bilbrey Director | CL Colgate-Palmolive Company | 6,329 | $579.7K | — | May 1, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 55,486 | $4.7M | — | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 14,462 | $1.2M | 10b5-1 | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 3,538 | $299.6K | 10b5-1 | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 16, 2024 | Parameswaran Prabha Officer | CL Colgate-Palmolive Company | 56,836 | $4.8M | — | Feb 16, 2024 | — | Form 144 ↗ |
| Feb 16, 2024 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 29,772 | $2.5M | 10b5-1 | Feb 16, 2024 | — | Form 144 ↗ |
| Feb 16, 2024 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 5,790 | $486.1K | 10b5-1 | Feb 16, 2024 | — | Form 144 ↗ |
| Feb 12, 2024 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 50,000 | $4.2M | 10b5-1 | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 1, 2024 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 61,633 | $5.2M | 10b5-1 | Feb 1, 2024 | — | Form 144 ↗ |
| Jan 31, 2024 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 30,433 | $2.6M | — | Jan 31, 2024 | — | Form 144 ↗ |
| Jan 31, 2024 | C. Martin Harris Director | CL Colgate-Palmolive Company | 2,760 | $233.2K | — | Jan 31, 2024 | — | Form 144 ↗ |
| Nov 30, 2023 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 3,800 | $300.2K | 10b5-1 | Nov 30, 2023 | — | Form 144 ↗ |
| Nov 28, 2023 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 15,000 | $1.2M | — | Nov 28, 2023 | — | Form 144 ↗ |
| Nov 13, 2023 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 20,000 | $1.5M | — | Nov 10, 2023 | — | Form 144 ↗ |
| Nov 3, 2023 | John T. Cahill Director | CL Colgate-Palmolive Company | 6,329 | $474.2K | — | Nov 3, 2023 | — | Form 144 ↗ |
| Nov 2, 2023 | Lorrie M. Norrington Director | CL Colgate-Palmolive Company | 6,329 | $471.9K | — | Nov 2, 2023 | — | Form 144 ↗ |
| Nov 1, 2023 | Michael B. Polk Director | CL Colgate-Palmolive Company | 13,019 | $979.4K | — | Nov 1, 2023 | — | Form 144 ↗ |
| Sep 11, 2023 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 24,704 | $1.8M | 10b5-1 | Sep 11, 2023 | — | Form 144 ↗ |
| Sep 11, 2023 | Noel R. Wallace Officer, Director | CL Colgate-Palmolive Company | 48,627 | $3.6M | 10b5-1 | Sep 11, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Jennifer Daniels Officer | CL Colgate-Palmolive Company | 24,703 | $2.0M | 10b5-1 | May 19, 2023 | — | Form 144 ↗ |
| May 10, 2023 | Mejia Maria Fernanda Member of immediate family of any of th… | CL Colgate-Palmolive Company | 2,404 | $194.7K | — | May 10, 2023 | — | Form 144 ↗ |
| May 10, 2023 | Tsourapas Panagiotis Officer | CL Colgate-Palmolive Company | 13,698 | $1.1M | — | May 10, 2023 | — | Form 144 ↗ |
| May 9, 2023 | John P. Bilbrey Director | CL Colgate-Palmolive Company | 5,703 | $460.9K | — | May 9, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances